Inspire Medical Systems, Inc. (NYSE:INSP) Shares Sold by William Blair Investment Management LLC

William Blair Investment Management LLC lessened its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 0.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 902,611 shares of the company's stock after selling 3,738 shares during the period. William Blair Investment Management LLC owned about 3.01% of Inspire Medical Systems worth $167,326,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Mutual of America Capital Management LLC lifted its position in shares of Inspire Medical Systems by 1.2% during the fourth quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company's stock valued at $842,000 after buying an additional 55 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Inspire Medical Systems by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company's stock worth $1,461,000 after purchasing an additional 79 shares in the last quarter. Harbour Investments Inc. raised its stake in Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock valued at $37,000 after buying an additional 99 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Inspire Medical Systems by 37.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 368 shares of the company's stock valued at $68,000 after acquiring an additional 100 shares in the last quarter. Finally, Louisiana State Employees Retirement System raised its position in shares of Inspire Medical Systems by 0.7% in the 4th quarter. Louisiana State Employees Retirement System now owns 14,500 shares of the company's stock valued at $2,688,000 after purchasing an additional 100 shares during the last quarter. Institutional investors own 94.91% of the company's stock.

Remove Ads

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of Inspire Medical Systems stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the transaction, the chief technology officer now directly owns 10,424 shares of the company's stock, valued at $1,777,187.76. The trade was a 5.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Randy Ban sold 25,584 shares of the firm's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the sale, the insider now owns 7,259 shares of the company's stock, valued at $1,332,026.50. This represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,225 shares of company stock valued at $4,806,530. 4.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

INSP has been the topic of a number of recent analyst reports. Robert W. Baird cut their price target on shares of Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 11th. Piper Sandler dropped their target price on Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a research report on Monday, February 10th. Stifel Nicolaus cut their price target on shares of Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating on the stock in a report on Tuesday, January 21st. Truist Financial decreased their price objective on shares of Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating for the company in a research note on Tuesday, February 11th. Finally, Wells Fargo & Company cut their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 11th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, Inspire Medical Systems has an average rating of "Moderate Buy" and a consensus price target of $228.82.

Inspire Medical Systems Price Performance

INSP stock traded up $1.64 during mid-day trading on Friday, reaching $164.39. 571,748 shares of the company's stock were exchanged, compared to its average volume of 579,682. The company has a market cap of $4.88 billion, a price-to-earnings ratio of 95.02, a price-to-earnings-growth ratio of 2.86 and a beta of 1.48. Inspire Medical Systems, Inc. has a 12-month low of $123.00 and a 12-month high of $257.40. The stock's 50 day moving average is $181.05 and its 200 day moving average is $191.43.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. On average, research analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.